PET/MRI融合显像在脑胶质瘤诊断和治疗中的研究进展

高艳 ,  赵晋华

downloadPDF
文章导航 > 国际放射医学核医学杂志  > 2015,  39 > 1: (71-74,79)  
引用本文:
shu
Citation:
shu

PET/MRI融合显像在脑胶质瘤诊断和治疗中的研究进展

The advancement of PET/MRI on the diagnosis and treatment of brain gliomas

  • Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai 200080, China

    • Corresponding author: Zhao Jinhua, email:zhaojinhua1963@126.com

  • 摘要: 脑胶质瘤发病率较高,是颅内最常见的原发肿瘤。MRI技术在脑胶质瘤分级、手术定位和术后放疗靶区勾画中有着重要的作用。但是,越来越多的研究发现,MRI在肿瘤显像方面仍存在局限性,如准确确定肿瘤边界。PET利用组织代谢原理进行功能显像,有利于发现增殖活跃的肿瘤组织。PET与MRI图像的融合,实现了解剖与功能共同显像,为提高脑胶质瘤诊断的准确性提供了一条新途径。
    Abstract: There is a high incidence of glioma which is the most common primary intracranial tumor. MRI has been dominant in grading tumors, fixing the position for operations and targeting volume delineation for postoperative radiotherapy of gliomas. Nevertheless more and more researches have demonstrated its pitfalls on several aspects of tumors, such as defining the exact border. Whereas, PET showing the metabolism is skilled in seeking vigorous tumors. It is an innovative approach for the hybrid of PET and MRI to improve the diagnosis of gliomas.
  • [1] Zene Q S,Liu H P,Zhang K,et a1.Noninvasive evaluation of cere-bral glioma grade by using multivoxel 3D proton MR spectroscopy[J].Magn Reson Imaging,2011,29(1):25-31.
    [2] Bai X,Zhang Y T,Liu Y,et al.Grading of supratentorial astrocytic tumors by using the difference of ADC value[J].Neuroradiology,2011,53(7):533-539.
    [3] Server A,Kulle B,Gadmar ØB,et al.Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton M R spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas[J].Eur J Radiol,2011,80(2):462-470.
    [4] Arvinda HR,Kesavadas C,Sarma PS,et al.Glioma grading:sensi-tivity,specificity,positive and negative predictive values of diffu-sion and perfusion imaging[J].J Neurooncol,2009,94(1):87-96.
    [5] Saitta L,Heese O,Förster AF,et al.Signal intensity in T2' magnetic resonance imaging is related to brain glioma grade[J].Eur Radiol,2011,21(5):1068-1076.
    [6] Padma MV,Said S,Jacobs M,et al.Prediction of pathology and survival by FDG PET in gliomas[J].J Neurooneol,2003,64(3):227-237.
    [7] 程勋全,钱立庭.PET/CT显像剂在脑胶质瘤中的应用研究进展[J].中国实验诊断学,2009,13(9):1308-1310.
    [8] 蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国外医学:放射医学核医学分册,2005,29(1):10-14.
    [9] 韩志铁,苏少波,雪亮,等.11C-METPET与MRI影像融合技术在胶质瘤术前评价和术中导航中的应用价值[J].中国现代神经疾病杂志,2013,13(4):324-329.
    [10] Pöpperl G,Kreth FW,Mehrkens JH,et al.FET PET for the evalua-tion of untreated gliomas:correlation of FET uptake and uptake kinetics with tumor grading[J].Eur J Nucl Med Mol Imaging,2007,34(12):1933-1942.
    [11] Mertens K,Acou M,Van Hauwe J,et al.Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas:a stereotactic PET and MRI study[J].Clin Nucl Med,2013,38(7):495-500.
    [12] Holodny AI,Makeyev S,Beattie BJ,et al.Apparent diffusion coef-ficient of glial neoplasms:correlation with fluorodeoxyglucose-e-mission tomography and gadolinium-enhanced MR imaging[J].AJNR A m J Neurodiol,2010,31(6):1042-1048.
    [13] Gempt J,Soehngen E,Forster S,et al.Multimodal imaging in cere-bral gliomas and its neuropathological correlation[J].Eur J Radi-ol,2014,83(5):829-834.
    [14] Rahm V,Boxheimer L,Bruehlmeier M,et al.Focal changes in dif-fusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-gradegliomas[J].J Nucl Med,2014,55(4):546-550.
    [15] Kelly PJ,Daumas-Duport C,Scheithauer BW,et al.Stereotactic histologic correlations of computed tomography-and magnetic reso-nance imaging-defined abnormalities in patients with glial neo-plasms[J].Mayo Clin Proc,1987,62(6):450-459.
    [16] Pauleit D,Floeth F,Hamacher K,et al.O-(2-18F-fluoroethy)-L-ty-rosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas[J].Brain,2005,128(pt3):678-687.
    [17] Tanaka Y,Nariai T,Momose T,et al.Glioma surgery using a multi-modal navigation system with integrated metabolic images[J].J Neurosurg,2009,110(1):163-172.
    [18] Miwa K,Shinoda J,Yano H,et al.Discrepancy between lesion dis-tributions on methionine PET and M R images in patients with glioblastoma multiforme:insight from a PET and MR fusion image study[J].J Neurol Neurosury Psychiatry,2004,75(10):1457-1462.
    [19] 郭旭,郭毅,程欣,等.PET-MRI影像融合技术在胶质瘤的活组织检查和手术中的应用[J].中华医学杂志,2013,93(1):15-18.
    [20] 邓美玲,吴少雄,黄绍敏,等.11C-MET PET和MRI对脑高级别神经胶质瘤术后放疗靶区设定的比较研究[J].中华放射肿瘤学杂志,2010,19(5):415-419.
    [21] Braun V,Dempf S,Weller R,et al.Cranial neuronavigation with di-rect integration of 11C methionine positron emission tomography(PET) data-results of a pilot study in 32 surgical cases[J].Acta Neurochir(Wien),2002,144(8):777-782.
    [22] Pirotte B,Goldman S,Massager N,et al.Combined use of [F-18] fluorodeoxyglucose and[C-11] methionine in 45 PET-guided stereo-tactic brain biopsies[J].J Neurosurg,2004,101(3):476-483.
    [23] Pirotte B,Goldman S,Massager N,et al.Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy in gliomas[J].J Nucl Med,2004,45(8):1293-1298.
    [24] Navarria P,Reggionri G,Pessina F,et al.Investigation on the role of integratea PET/MRI ior target volume definition and radiothera-py planning in patients with high grade glioma[J].Radiother Oncol,2014,112(3):425-429.
    [25] Filss CP,Stoffels G,Galldiks N,et al.Histogram analysis reveals a better delineation of tumor volume from background in 18F-FET PET compared to CBV maps in a hybrid PET-MR studie in gliomas[J].Nucl Instrum Methods Phy Res A,2014,734:175-178.
    [26] Rieken S,Habermehl D,Giesel FL,et al.Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy[J].Radiother Oncol,2013,109(3):487-492.
    [27] Chao ST,Suh JH,Raja S,el al.The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecro-sis in patients treated with stereotactic radiosurgery[J].Int J Cancer,2001,96(3):191-197.
    [28] Chung JK,Kim YK,Kim SK,et al.Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo-or isometabolic on 18F-FDG PET[J].Eur J Nucl Med Mol Imaging,2002,29(2):176-182.
    [29] Chen W.Clinical applications of PET in brain tumors[J].J Nucl Med,2007,48(9):1468-1481.
    [30] D,Souza MM,Sharma R,Jaimini A,et al.11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas[J].Clin Nucl Med,2014,39(9):791-798.
    [31] Grosu AL,Weber WA,Riedel E,et al.L-(methyl)11C-methionine positron emission tomography for target delineation in resected highgrade gliomas before radiotherapy[J].Int J Radiat Oncol Biol Phys,2005,63(1):64-74.
    [32] Galldiks N,Stoffels G,Ruge MI,et al.Role of O-(2-18F-Fluo-roethyl)-L-tyrosine PET as a diagnostic tool for detection of mali-gant progression in patients with low-grade glioma[J].J Nucl Med,2013,54(12):2046-2054.
    [33] Jansen NL,Schwartz C,Graute V A,et al.Prediction of oligoden-droglial histology and LOH 1p/19q using dynamic[18F] FET-PETimaging in intracranial W H O grade Ⅱ and Ⅲ gliomas[J].NeuroOncol,2012,14(12):1473-1480.
    [34] Niyazi M,Jansen N,Ganswindt U,et al.Re-irradiation in recurrent malignant glioma:prognostic value of[18F] FET-PET[J].J Neuroon-col,2012,110(3):389-395.
    [35] Galldiks N,Rapp M,Stoffels G,et al.Response assessment of beva-cizumab inpatients with recurrent malignant glioma using[18F] Fluo-roethyl-1-tyrosine PET in comparison to MRI[J].Eur J Nucl Med Mol Imaging,2013,40(1):22-33.
  • [1] 高艳 , 赵晋华 . PET/MRI融合显像在脑胶质瘤诊断和治疗中的研究. 国际放射医学核医学杂志, 2015, 39(1): 71-74, 79.
    [2] 程林 , 程竞仪 . 氨基酸类正电子显像在胶质瘤中的研究进展. 国际放射医学核医学杂志, 2017, 41(4): 283-287. doi: 10.3760/cma.j.issn.1673-4114.2017.04.009
    [3] 孙娜 , 赵晋华 , 乔文礼 . 胶质瘤显像剂的研究与应用进展. 国际放射医学核医学杂志, 2011, 35(6): 330-334. doi: 10.3760,cma.j.issn.1673-4114.2011.06.003
    [4] 潘越 , 王观筠 , 党浩丹 , 徐白萱 . RGD肽类示踪剂及其PET显像在脑胶质瘤诊疗中的应用. 国际放射医学核医学杂志, 2023, 47(6): 362-366. doi: 10.3760/cma.j.cn121381-202207012-00299
    [5] 孙娜 , 赵晋华 , 乔文礼 . 胶质瘤显像剂的研究与应用进展. 国际放射医学核医学杂志, 2011, 35(6): 330-334. doi: 10.3760/cma.j.issn.1673-4114.2011.06.003
    [6] 展凤麟 , 汪世存 , 潘博 , 倪明 , 谢吉奎 , 谢强 , 钱立庭 . 11C-胆碱和18F-FDG PET/CT显像在脑胶质瘤诊断中的应用. 国际放射医学核医学杂志, 2013, 37(4): 193-195. doi: 10.3760/cma.j.issn.1673-4114.2013.04.001
    [7] 程勇军 , 赵晋华 . 东亚钳蝎氯毒素在胶质瘤靶向显像与治疗中的研究进展. 国际放射医学核医学杂志, 2015, 39(1): 32-36. doi: 10.3760/cma.j.issn.1673-4114.2015.01.008
    [8] 周惠君 , 董萍 , 沈国华 , 李林 . 11C-蛋氨酸PET/CT显像在脑胶质瘤中的应用价值. 国际放射医学核医学杂志, 2015, 39(2): 161-164. doi: 10.3760/cma.j.issn.1673-4114.2015.02.013
    [9] 刘道佳 , 吴君心 , 唐明灯 , 林端瑜 , 张杰平 , 李生栩 , 蔡志华 , 吕清湖 . 18F-FLT PET/CT显像评估复发脑胶质瘤患者预后的价值. 国际放射医学核医学杂志, 2018, 42(5): 403-408. doi: 10.3760/cma.j.issn.1673-4114.2018.05.003
    [10] 孙达 . 双语认知的功能性脑显像研究. 国际放射医学核医学杂志, 2008, 32(6): 325-328.
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  1897
  • HTML全文浏览量:  169
  • PDF下载量:  5
出版历程
  • 收稿日期:  2014-11-15

PET/MRI融合显像在脑胶质瘤诊断和治疗中的研究进展

  • 收稿日期: 2014-11-15

摘要: 脑胶质瘤发病率较高,是颅内最常见的原发肿瘤。MRI技术在脑胶质瘤分级、手术定位和术后放疗靶区勾画中有着重要的作用。但是,越来越多的研究发现,MRI在肿瘤显像方面仍存在局限性,如准确确定肿瘤边界。PET利用组织代谢原理进行功能显像,有利于发现增殖活跃的肿瘤组织。PET与MRI图像的融合,实现了解剖与功能共同显像,为提高脑胶质瘤诊断的准确性提供了一条新途径。

English Abstract

    全文HTML

参考文献 (35)

目录

    /

    返回文章
    返回

    版权所有©中华医学会   备案号：津ICP备15006720号-3

    地址：天津市南开区白堤路238号电话：86-22-58089989
    86-22-85682389    传真：022-87890607

    本系统由 北京仁和汇智信息技术有限公司 开发 技术支持： info@rhhz.net